Rocuronium bromide

Cortistatin 14.

CVN424 is an orally active and selective GPR6 inverse agonist with a K i of 9.4 nM and an EC 50 of 38 nM. CVN424 is brain-penetrant and has the potential for Parkinson disease researchIn VitroCVN424 (Compound 6i) has 265 fold and 68 fold

CVN424 is an orally active and selective GPR6 inverse agonist with a K i of 9.4 nM and an EC 50 of 38 nM. CVN424 is brain-penetrant and has the potential for Parkinson disease researchIn VitroCVN424 (Compound 6i) has 265 fold and 68 fold

CVN424 is an orally active and selective GPR6 inverse agonist with a K i of 9.4 nM and an EC 50 of 38 nM. CVN424 is brain-penetrant and has the potential for Parkinson disease researchIn VitroCVN424 (Compound 6i) has 265 fold and 68 fold

DCLK1-IN-1 is a selective, in vivo-compatible chemical probe of the doublecortin like kinase 1 (DCLK1) domain that binds to DCLK1 and DCLK2 with IC50 of 9.5 nM and 31 nM, respectively. DCLK1-IN-1 inhibits DCLK1 and DCLK2 kinases with IC50 of 57.2 nM

5-Bromo-N-(4-bromophenyl)-2-hydroxy-benzamide (CAS# 87-12-7) is a useful research chemical compound.

5-Bromo-N-(4-bromophenyl)-2-hydroxy-benzamide (CAS# 87-12-7) is a useful research chemical compound.

5-Bromo-N-(4-bromophenyl)-2-hydroxy-benzamide (CAS# 87-12-7) is a useful research chemical compound.

5-Bromo-N-(4-bromophenyl)-2-hydroxy-benzamide (CAS# 87-12-7) is a useful research chemical compound.

5-Bromo-N-(4-bromophenyl)-2-hydroxy-benzamide (CAS# 87-12-7) is a useful research chemical compound.

Product Describtion:Entrectinib (RXDX-101, NMS-E628) is an orally bioavailable pan-TrkA/B/C, ROS1 and ALK inhibitor with IC50 ranging between 0.1 and 1.7 nM. Entrectinib (RXDX-101) induces autophagy.

Product Describtion:Entrectinib (RXDX-101, NMS-E628) is an orally bioavailable pan-TrkA/B/C, ROS1 and ALK inhibitor with IC50 ranging between 0.1 and 1.7 nM. Entrectinib (RXDX-101) induces autophagy.